ArticleHepatology international2023

Methylated SEPT9 assay-based liquid biopsy as a biomarker in molecular targeted agent-treated hepatocellular carcinoma.

Issei Saeki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.